Hansa Biopharma
Develops antibody-cleaving enzyme medicines for patients with rare immune-mediated diseases and transplant desensitisation
Highlights
- Hiring2 open roles
About Hansa Biopharma
Hansa Biopharma is a commercial-stage biopharmaceutical company developing immunomodulating treatments for rare immunological conditions. Its proprietary antibody-cleaving enzyme platform includes imlifidase and HNSA-5487, which target pathogenic IgG antibodies. The pipeline covers autoimmune diseases, desensitisation in transplantation and desensitisation in gene therapy.
The company's customers are patients with acute or serious immune-mediated conditions. Besides commercialising its own therapies, Hansa works with partners in drug discovery and development, commercialisation, and distribution and licensing.
Founded in 2007, Hansa is based in Lund, Sweden, and is listed on Nasdaq Stockholm. The company describes a growing presence in Europe and the US and a workforce with more than 30 nationalities. Current openings include Key Account Manager roles in multiple US cities, along with quality assurance and HR positions in Lund.
Product: Imlifidase, a first-generation antibody-cleaving enzyme, and HNSA-5487, a next-generation enzyme in development for IgG-driven immune conditions.
Jobs at Hansa Biopharma (2)
Hansa Biopharma is hiring for 2 roles in engineering and HR, based in Lund.
Companies hiring like Hansa Biopharma
Leadership
- Renée Aguiar-Lucander · Chief Executive OfficerSource: company website
- Adam Cutler · Chief Financial OfficerSource: company website
- Hitto Kaufmann · Chief Scientific & Technology OfficerSource: company website
- Maria Törnsén · Chief Operating Officer and President U.S.Source: company website
- Sandra Frithiof · Chief Human Resources OfficerSource: company website
More biotech & pharma companies
HAYA Therapeutics
Develops RNA-guided medicines that target non-coding RNAs in disease, with Eli Lilly as a collaboration partnerIambic Therapeutics
AI-enabled drug discovery and therapeutic development for patients and pharmaceutical partnersRemote-friendlyIllumina
DNA sequencing, microarray, and genomics software solutions for researchers, clinicians, and laboratoriesNew on EvolcRemote-friendlySalary transparentImmunic Therapeutics
Develops oral small-molecule therapies for patients with neurologic, inflammatory and autoimmune diseasesSalary transparentInceptive
AI foundation models that design sequence-based drug candidates such as mRNA, siRNA and ASOs for pharma partnersSalary transparentJsrglobal
Contract development and cGMP manufacturing of biologics, plus analytical testing, for biopharmaceutical companiesNew on EvolcRemote-friendlySalary transparent
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Cloudflare
- OneTrust
- Teamtailor